Streptococcal Infections

  • Barry M. Gray


The streptococci are a large heterogeneous group of grampositive spherically shaped bacteria found widely distributed in nature. They include some of the most important agents of human disease, as well as members of the normal human flora. Some streptococci have been associated mainly with disease in animals, while others have been domesticated and used for the culture of buttermilk, yogurt, and certain cheeses. Those known to cause human disease can be thought of as comprising two broad categories: First are the pyogenic streptococci, including the familiar β3-hemolytic streptococci and the pneumococcus. These organisms are not generally part of the normal flora but cause acute, often severe, infections in normal hosts. Second are the more diverse enteric and oral streptococci, which are nearly always part of the normal flora and which are more frequently associated with opportunistic infections.


Minimal Inhibitory Concentration Rheumatic Fever Rheumatic Heart Disease Capsular Polysaccharide Streptococcal Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Anderson, P., and Betts, R., Human adult immunogenicity of protein-coupled pneumococcal capsular antigens of serotypes prevalent in otitis media, Pediatr. Infect. Dis. J. 8:S50–S53 (1989).CrossRefGoogle Scholar
  2. 2.
    Andersson, B., Gray, B. M., Dillon, H. C., Jr., Bahrmand, A., and Svanborg-Eden, C., Role of adherence of Streptococcus pneumoniae in acute otitis media, Pediatr. Infect. Dis. J. 7:476–480 (1988).PubMedCrossRefGoogle Scholar
  3. 3.
    Anthony, B. F., Concepcion, N. F., Wass, C. A., and Heiner, D. C., Immunoglobin G and M composition of naturally occurring antibody to type Iii group B streptococci, Infect. Immun. 46:98–104 (1984).PubMedGoogle Scholar
  4. 4.
    Appelbaum, P. C., World-wide development of antibiotic resistance in pneumococci, Eur. J. Clin. Microbiol. 6:367–377 (1987).PubMedCrossRefGoogle Scholar
  5. 5.
    Arditi, M., Shulman, S. T., Davis, T., and Yogev, R., Group C β-hemolytic streptococcal infections in children: Nine pediatric cases and review, Rev. Infect. Dis. 11:34–45 (1989).CrossRefGoogle Scholar
  6. 6.
    Arends, J. P., and Zanen, H. C., Meningitis caused by Streptococcus suis in humans, Rev. Infect. Dis. 10:131–137 (1988).PubMedCrossRefGoogle Scholar
  7. 7.
    Austrian, R., Pneumococcus: The first one hundred years, Rev. Infect. Dis. 3:183–189 (1981).PubMedCrossRefGoogle Scholar
  8. 8.
    Avery, O. T., Macleod, C. M., and Mccarty, M., Studies on the chemical nature of the substance inducing transformation of pneumococcal types: Induction of transformation by a desoxyribonucleic acid, J. Exp. Med. 79:137–158 (1944).PubMedCrossRefGoogle Scholar
  9. 9.
    Ayoub, E. M., Barrett, D. J., Maclaren, N. K., and Krischer, J. P., Association of class Ii human histocompatibility leukocyte antigens with rheumatic fever, J. Clin. Invest. 77:2019–2026 (1986).PubMedCrossRefGoogle Scholar
  10. 10.
    Backhouse, C. I., and Cartwright, R. Y., An outbreak of streptococcal skin sepsis in a closed community, Br. Med. J. 3:497–499 (1974).PubMedCrossRefGoogle Scholar
  11. 11.
    Baker, C. J., and Kasper, D. L., Group B streptococcal vaccines, Rev. Infect. Dis. 7:458–467 (1985).PubMedCrossRefGoogle Scholar
  12. 12.
    Baker, C. J., Edwards, M. S., and Kasper, D. L., Role of antibody to native type Iii polysaccharide of group B streptococcus in infant infections, Pediatrics 68:544–549 (1981).PubMedGoogle Scholar
  13. 13.
    Baker, C. J., Rench, M. A., Edwards, M. S., Carpenter, R. J., Hays, B. M., and Kasper, D. L., Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus, N. Engl. J. Med. 319:1180–1185 (1988).PubMedCrossRefGoogle Scholar
  14. 14.
    Bassett, D. C. J., Hippelates flies and acute nephritis, Lancet 1:503 (1967).CrossRefGoogle Scholar
  15. 15.
    Beachey, E. H., and Courtney, H. S., Bacterial adherence: The attachment of group A streptococci to mucosal surfaces, Rev. Infect. Dis. 9(Suppl.): S475–S481 (1987).CrossRefGoogle Scholar
  16. 16.
    Becroft, D. M. O., Farmer, J., Mason, J. H., and Morris, M. C., Perinatal infections by group B β-hemolytic streptococci, Br. J. Obstet. Gynaecol. 83:960–966 (1976).PubMedCrossRefGoogle Scholar
  17. 17.
    Bessen, D., and Fischetti, V. A., Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci, Infect. Immun. 56:2666–2672 (1988).PubMedGoogle Scholar
  18. 18.
    Bolan, G., Broome, C. V., Facklam, R. R., Plikaytis, B. D., Fraser, D. W., and Schlech, W. F,. III, Pneumococcal vaccine efficacy in selected populations in the United States, Ann. Intern. Med. 104:1–6 (1986).PubMedGoogle Scholar
  19. 19.
    Borzy, M. S., Wolff, L., Gewurz, A., Buist, N. R., and Lovrien, E., Recurrent sepsis with deficiereies of C2 and galactosidase, Am. J. Dis. Child. 138:186–191 (1984).PubMedGoogle Scholar
  20. 20.
    Boyer, K. M., and Gotoff, S. P., Prevention of neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis, N. Engl. J. Med. 314:1665–1669 (1986).PubMedCrossRefGoogle Scholar
  21. 21.
    Boyer, K. M., Vogel, L. C., Gotoff, S. P., Gadzala, C. A., Stringer, J., and Maxted, W. R., Nosocomial transmission of bacteriophage type 7/11/12 group B streptococci in a special care nursery, Am. J. Dis. Child. 134:964–966 (1980).PubMedGoogle Scholar
  22. 22.
    Boyer, K. M., Gadzala, C. A., Burd, L. I., Fisher, D. E., Paton, J. B., and Gotoff, S. P., Selective intrapartum chemoprophylaxis of neonatal group B streptococcal earlyonset disease. I. Epidemiologic rationale, J. Infect. Dis. 148:795–801 (1983).PubMedCrossRefGoogle Scholar
  23. 23.
    Braconier, J. H., Nilsson, B., Oxelius, V. A., and Karup-Pedersen, F., Recurrent pneumococcal infections in a patient with lack of specific IgG and IgM pneumococcal antibodies and deficiency of serum IgA, IgG2 and IgG4, Scand. J. Infect. Dis. 16:407–410 (1984).PubMedCrossRefGoogle Scholar
  24. 24.
    Bratton, L., Teele, D. W., and Klein, J. O., Outcome of unsuspected pneumococcemia in children not initially admitted to the hospital, J. Pediatr. 90:703–706 (1977).PubMedCrossRefGoogle Scholar
  25. 25.
    Breese, B. B., Disney, F. A., and Talpey, W., The nature of a small pediatric group practice. Ii. The incidence of beta streptococcal illness in a private pediatric practice, Pediatrics 38:277–285 (1966).PubMedGoogle Scholar
  26. 26.
    Breese, B. B., Denny, F. W., Dillon, H. C., Jr., Stillerman, M., Nelson, J. D., and Mccracken, G. H., Consensus: Difficult management problems in children with streptococcal pharyngitis, Pediatr. Infect. Dis. J. 4:10–13 (1985).CrossRefGoogle Scholar
  27. 27.
    Briles, D. E., Scott, G., Gray, B. M., Crain, M. J., Blaese, M., Nahm, M., Scott, V., and Haber, P., Naturally occurring antibodies to phosphocholine as a potential index of antibody responsiveness to polysaccharides, J. Infect. Dis. 155:1307–1314 (1987).PubMedCrossRefGoogle Scholar
  28. 28.
    Brimblecombe, F. S. W., Cruickshank, R., Masters, P. L., and Reid, D. D., Family studies of respiratory infections, Br. Med. J. 1:119–128 (1958).PubMedCrossRefGoogle Scholar
  29. 29.
    Brook, I., Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococci, Pediatr. Infect. Dis. J. 4:491–495 (1985).CrossRefGoogle Scholar
  30. 30.
    Bryan, C. S., Reynolds, K. L., and Brown, J. S., Mortality associated with enterococcal bacteremia, Surg. Gynecol. Obstet. 160:557–561 (1985).PubMedGoogle Scholar
  31. 31.
    Buntain, W. L., and Lynn, H. B., Splenorrhaphy: Changing concepts for the traumatized spleen, Surgery 86:748–760 (1979).PubMedGoogle Scholar
  32. 32.
    Butter, M. N., and Demoor, C. E., Streptococcus agalactiae as a cause of meningitis in the newborn, and of bacteraemia in adults, Antonie van Leeuwenhoek J. Microbiol. Serol. 33:439–450 (1967).CrossRefGoogle Scholar
  33. 33.
    Centers for Disease Control, Update: Pneumococcal polysaccharide vaccine usage-United States, Morbid. Mortal. Weekly Rep. 33:273–281 (1984).Google Scholar
  34. 34.
    Centers for Disease Control, Group A, β hemolytic Streptococcus skin infections in a meat-packing plant-Oregon, Morbid. Mortal. Weekly Rep. 35:629–630 (1986).Google Scholar
  35. 35.
    Centers for Disease Control, Acute rheumatic fever at a Navy training center, San Diego, California, Morbid. Mortal. Weekly Rep. 37:101–104 (1988).Google Scholar
  36. 36.
    Chhatwal, G. S., Dutra, I. S., and Blobel, H., Fibrinogen binding inhibits the fixation of the third component of human complement on surface of group A, B, C, and G streptococci, Microbiol. Immunol. 29:973–980 (1985).PubMedGoogle Scholar
  37. 37.
    Christie, C. D. C., Havens, P. L., and Shapiro, E. D., Bacteremia with group A streptococci in childhood, Am. J. Dis. Child. 142:559–561 (1988).PubMedGoogle Scholar
  38. 38.
    Christie, R., Atkins, N. E., and Munch-Petersen, E., A note on a lytic phenomenon shown by group B streptococci, Aust. J. Exp. Biol. Med. Sci. 22:197–200 (1944).CrossRefGoogle Scholar
  39. 39.
    Chun, L. T., Reddy, D. V., and Yamamoto, L. G., RheumatiC fever in children and adolescents in Hawaii, Pediatrics 79:549–552 (1987).PubMedGoogle Scholar
  40. 40.
    Clancy, R. L., Cripps, A. W., Husband, A. J., and Buckley, D., Specific immune response in the respiratory tract after administration of an oral polyvalent bacterial vaccine, Infect. Immun. 39:491–496 (1983).PubMedGoogle Scholar
  41. 41.
    Cleat, P. H., and Timms, K. N., Cloning and expression in Escherichia coli of the Ibc protein genes of group B streptococci: Binding of human immunoglobin A to the beta antigen, Infect. Immun. 55:1151–1155 (1987).PubMedGoogle Scholar
  42. 42.
    Cochi, S., and Feldman, R., Estimating national incidence of group B streptococcal disease: The effect of adjusting for birth weight, Pediatr. Infect. Dis. J. 2:414–415 (1983).CrossRefGoogle Scholar
  43. 43.
    Committee on Issues and Priorities for New Vaccine Development, National Academy of Science Institute of Medicine, New Vaccine Development: Establishing Priorities, Volume I, Diseases of Importance in the United States, National Academy Press, Washington, D.C., 1985.Google Scholar
  44. 44.
    Committee on Issues and Priorities for New Vaccine Development, National Academy of Science Institute of Medicine, New Vaccine Development: Establishing Priorities, Volume II, Diseases of Importance in Developing Countries, National Academy Press, Washington, D.C., 1986.Google Scholar
  45. 45.
    Committee on Prevention of Rheumatic Fever and Bacterial Endocarditis of the American Heart Association, Prevention of bacterial endocarditis, Circulation 70:1123A (1984).Google Scholar
  46. 46.
    Cone, L. A., Woodward, D. R., Schlievert, P. M., and Tomory, G. S., Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes, N. Engl. J. Med. 317:146–149 (1987).CrossRefGoogle Scholar
  47. 47.
    Converse, G. M., Iii, and Dillon, H. C., Jr., Epidemiological studies of Streptococcus pneumoniae in infants: Methods of isolating pneumococci, J. Clin. Microbiol. 5:293–296 (1977).PubMedGoogle Scholar
  48. 48.
    Craven, D. E., Rixinger, A. I., Bisno, A. L., Goularte, T. A., and Mccabe, W. R., Bacteremia caused by group G streptococci in parenteral drug abusers: Epidemiological and clinical aspects, J. Infect. Dis. 153:988–992 (1986).PubMedCrossRefGoogle Scholar
  49. 49.
    Cunningham, M. W., Mccormack, J. M., Talaber, L. R., Harley, J. B., Ayoub, E. M., Muneer, R. S., Chun, L. T., and Reddy, D. V., Human monoclonal antibodies reactive with antigens of the group A streptococcus and human heart, J. Immunol. 141:2760–2766 (1988).PubMedGoogle Scholar
  50. 50.
    D’Alessandri, R., Plotkin, G., Kluge, R. M., and Waldman, R. H., Protective studies with group A streptococcal M protein vaccine. Iii. Challenge of volunteers after systemic or intranasal immunization with type 3 or type 12 group A streptococcus, J. Infect. Dis. 138:712–718 (1978).PubMedCrossRefGoogle Scholar
  51. 51.
    Daugaard, H. O., Thomsen, A. C., Henriques, U., and Ostergaard, A., Group B streptococci in the lower urogenital tract and late abortions, Am. J. Obstet. Gynecol. 158:28–31 (1988).PubMedGoogle Scholar
  52. 52.
    Dillon, H. C., Derrick, C. W., and Dillon, M. S., Mantigens common to pyoderma and acute glomerulonephritis, J. Infect. Dis. 103:257–267 (1974).CrossRefGoogle Scholar
  53. 53.
    Dillon, H. C., Jr., Gbs: The childhood and adolescent years, Antibiot. Chemother. 35:1–9 (1985).PubMedGoogle Scholar
  54. 54.
    Dillon, H. C., Jr., Khare, S., and Gray, B. M., Group B streptococcal carriage and disease: A 6 year prospective study, J. Pediatr. 110:31–36 (1987).PubMedCrossRefGoogle Scholar
  55. 55.
    Douglas, R. M., Paton, J. C., Duncan, S. J., and Hansman, D. J., Antibody response to pneumococcal vaccination in children younger than five years of age, J. Infect. Dis. 148:131–137 (1983).CrossRefGoogle Scholar
  56. 56.
    Duma, R. J., Weinberg, A. N., Medrek, T. F., and Kuntz, L. G., Streptococcal infections, Medicine 48:87–127 (1969).CrossRefGoogle Scholar
  57. 57.
    Eads, M. E., Levy, N. J., Kasper, D. L., Baker, C. J., and Nicholson-Weber, A., Antibody-independent activation of Cl by type Ia group B streptococci, J. Infect. Dis. 146:665–671 (1982).PubMedCrossRefGoogle Scholar
  58. 58.
    Eickhoff, T. C., Klein, J. O., Daly, A. K., Ingal, P., and Finland, M., Neonatal sepsis and other infections due to group B beta-hemolytic streptococci, N. Engl. J. Med. 271:1221–1228 (1964).PubMedCrossRefGoogle Scholar
  59. 59.
    Eisenstein, T. K., De Cueninck, B. J., Resavy, D., Shockman, G. D., Carey, R. B., and Swenson, R. M., Quantitative determination in human sera of vaccine induced antibody to type-specific polysaccharides of group B streptococci using an enzyme-linked immunosorbant assay, J. Infect. Dis. 147:847–856 (1983).PubMedCrossRefGoogle Scholar
  60. 60.
    Facklam, R. R., and Carey, R. B., Streptococci and aerococci, in: Manual of Clinical Microbiology, 4th ed. (E. H. Lannette, ed.), pp. 154–175, American Society for Microbiology, Washington, D.C., 1985.Google Scholar
  61. 61.
    Fast, D. J., Schlievert, P. M., and Nelson, R. D., Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production, Infect. Immun. 57:291–294 (1989).PubMedGoogle Scholar
  62. 62.
    Fedson, D. S., Improving the use of pneumococcal vaccine through a strategy of hospital-based immunization, J. Am. Geriatr. Soc. 33:142–150 (1985).PubMedGoogle Scholar
  63. 63.
    Finch, R., Is pneumococcal infection a preventable disease? J. Infect. 17:95–98 (1988).PubMedCrossRefGoogle Scholar
  64. 64.
    Finland, M., Spring, W. C., and Lowell, F. C., Specific treatment of the pneumococcic pneumonias: An analysis of the results of serum therapy and chemotherapy at the Boston City Hospital from July 1938 through June 1939, Ann. Intern. Med. 13:1567–1593 (1940).Google Scholar
  65. 65.
    Fischer, G. W., Immunoglobin therapy of neonatal group B streptococcal infections: An overview, Pediatr. Infect. Dis. J. 7(Suppl): S13–S16 (1988).CrossRefGoogle Scholar
  66. 66.
    Gallagher, P. G., and Watanakunakorn, C., Group B streptococcal endocarditis: Report of seven cases and review of the literature, 1962–1985, Rev. Infect. Dis. 8:175–188 (1986).PubMedCrossRefGoogle Scholar
  67. 67.
    Gaworzewska, E., and Colman, G., Changes in the pattern of infection caused by Streptococcus pyogenes, Epidemiol. Infect. 100:257–269 (1988).CrossRefGoogle Scholar
  68. 68.
    Gerber, M. A., Randolph, M. F., and Mayo, D. R., The group A streptococcal carrier state: A reexamination, Am. J. Dis. Child. 142:562–565 (1988).PubMedGoogle Scholar
  69. 69.
    Gibberd, G. F., Puerperal sepsis 1930–1965, J. Obstet. Gynaecol. Br. Commonw. 73:1–10 (1966).PubMedCrossRefGoogle Scholar
  70. 70.
    Giebink, G. S., Preventing pneumococcal disease in children: Recommendations for using pneumococcal vaccine, Pediatr. Infect. Dis. J. 4:343–348 (1985).CrossRefGoogle Scholar
  71. 71.
    Ginsburg, I., Streptococcal enzymes and virulence, in: Bacterial Enzymes and Virulence (I. A. Holder, ed.), pp. 122–144, Crc Press, Boca Raton, 1985.Google Scholar
  72. 72.
    Glass, R. L., Alman, J. E., and Chauncy, H. H., A 10year longitudinal study of caries incidence rates in a sample of male adults in the Usa, Caries Res. 21:360–367 (1987).PubMedCrossRefGoogle Scholar
  73. 73.
    Gnann, J. W., Jr., Gray, B. M., Griffin, F. M., Jr., and Dismukes, W. E., Acute glomerulonephritis following group G streptococcal infection. J. Infect. Dis. 156:411–412 (1987).PubMedCrossRefGoogle Scholar
  74. 74.
    Goldmann, D. A., and Breton, S. J., Group C streptococcal surgical wound infections transmitted by an anorectal and nasal carrier, Pediatrics 61:235–237 (1978).Google Scholar
  75. 75.
    GooD, R. A., and Pahwa, R. N. (eds.), The recognition and management of immunodeficient disorders, Pediatr. Infect. Dis. J. 7(Suppl.): S2–S125 (1988).Google Scholar
  76. 76.
    Gosling, J., Occurrence and pathogenicity of the Streptococcus milleri group, Rev. Infect. Dis. 10:257–285 (1988).CrossRefGoogle Scholar
  77. 77.
    Gotoff, S. P., Odell, C., Papierniak, C. P., Klegerman, M. E., and Boyer, K. M., Human IgG antibody to group B Streptococcus type III: Comparison of protective levels in a murine model with levels in infected human neonates, J. Infect. Dis. 153:511–519 (1986).PubMedCrossRefGoogle Scholar
  78. 78.
    Gray, B. M., and Dillon, H. C., Jr., Gbs infections in mothers and their infants, Antibiot. Chemother. 35:225–236 (1985).PubMedGoogle Scholar
  79. 79.
    Gray, B. M., and Dillon, H. C., Jr., Clinical and epidemiologic studies of pneumococcal infections in children, Pediatr. Infect. Dis. J. 5:201–207 (1986).CrossRefGoogle Scholar
  80. 80.
    Gray, B. M., and Dillon, H. C., Jr., Epidemiologic studies of Streptococcus pneumoniae in infants: Antibody to types 3, 6, 14, and 23 in the first two years of life, J. Infect. Dis. 158:948–955 (1988).CrossRefGoogle Scholar
  81. 81.
    Gray, B. M., and Dillon, H. C., Jr., Natural history of pneumococcal infections, Pediatr. Infect. Dis. J. 8(Suppl.): S23–S25 (1989).Google Scholar
  82. 82.
    Gray, B. M., Converse, G. M., Iii, and Dillon, H. C., Jr., Serotypes of Streptococcus pneumoniae causing disease, J. Infect. Dis. 140:979–983 (1979).PubMedCrossRefGoogle Scholar
  83. 83.
    Gray, B. M., Pass, M. A., and Dillon, H. C., Jr., Laboratory and field evaluation of selective media for isolation of group B streptococci, J. Clin. Microbiol. 9:466–470 (1979).PubMedGoogle Scholar
  84. 84.
    Gray, B. M., Converse, G. M., III, and Dillon, H. C., Jr., Epidemiologic studies of Streptococcus pneumoniae in infants: Acquisition, carriage and infection during the first 24 months of life, J. Infect. Dis. 146:923–933 (1980).CrossRefGoogle Scholar
  85. 85.
    Gray, B. M., Turner, M. E., and Dillon, H. C., Jr., Epidemiologic studies of Streptococcus pneumoniae in infants: The effects of season and age on pneumococcal acquisition and carriage in the first 24 months of life, Am. J. Epidemiol. 116:692–703 (1982).PubMedGoogle Scholar
  86. 86.
    Gray, B. M., Pritchard, D. G., and Dillon, H. C., Jr., Seroepidemiological studies of group B Streptococcus type Ii, J. Infect. Dis. 151:1073–1080 (1985).PubMedCrossRefGoogle Scholar
  87. 87.
    Gray, B. M., Dillon, H. C., Jr., Pritchard, D. G., Feinstein, R. A., Oh, K., and Michalek, S. M., Type-specific antibodies against group B streptococci in human serum, saliva and vaginal secretions, Adv. Exp. Med. Biol. 216:995–1003 (1987).Google Scholar
  88. 88.
    Gray, B. M., Pritchard, D. G., and Dillon, H. C., Jr., Seroepidemiology of group B Streptococcus type III at delivery, J. Infect. Dis. 159:1139–1142 (1989).PubMedCrossRefGoogle Scholar
  89. 89.
    Gullberg, R. M., The enterococcus, Infect. Control 7:600–606 (1986).PubMedGoogle Scholar
  90. 90.
    Håkansson, S., Holm, S. E., and Wagner, M., Density profile of group B streptococci, type III, and its possible relation to enhanced virulence, J. Clin. Microbiol. 25:714–718 (1987).PubMedGoogle Scholar
  91. 91.
    Haverkorn, M. J. (ed.), Streptococcal Disease and the Community, American Elsevier, New York, and Excerpta Medica, Amsterdam, 1974.Google Scholar
  92. 92.
    Hendley, J. O., Sande, M. A., Stewart, P. M., and Gwaltney, J. M., Jr., Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types, J. Infect. Dist. 132:55–61 (1975).CrossRefGoogle Scholar
  93. 93.
    Hodges, R. G., and Macleod, C. M., Epidemic pneumococcal pneumonia, Am. J. Hyg. 44:183–213 (1946).PubMedGoogle Scholar
  94. 94.
    Hood, J., and Janney, A., Beta hemolytic streptococcus group B associated with problems of the perinatal period, Am. J. Obstet. Gynecol. 82:809–818 (1961).PubMedGoogle Scholar
  95. 95.
    Hook, E. W., Hooton, T. M., Horton, C. A., Coyle, M. B., Ramsey, P. G., and Turck, M., Microbiologic evaluation of cutaneous cellulitis in adults, Arch. Intern. Med. 146:295–297 (1986).PubMedCrossRefGoogle Scholar
  96. 96.
    Hosier, D. M., Craemen, J. M., Teske, D. W., and Wheller, J. J., Resurgence of acute rheumatic fever, Am. J. Dis. Child. 141:730–732 (1987).PubMedGoogle Scholar
  97. 97.
    Hostetter, M. K., Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: Implications for phagocytosis and antibody production, J. Infect. Dis. 153:682–693 (1986).PubMedCrossRefGoogle Scholar
  98. 98.
    Huang, D. H., Krishna, N. R., and Pritchard, D. G., Characterization of the group A streptococcal polysaccharide by two-dimensional 1H-nuclear-resonance spectroscopy, Carbohydr. Res. 155:193–199 (1986).PubMedCrossRefGoogle Scholar
  99. 99.
    Ispahani, P., Donald, F. E., and Aveline, A. J. D., Streptococcus pyogenes bacteremia: An old enemy subdued but not defeated, J. Infect. 16:37–46 (1988).PubMedCrossRefGoogle Scholar
  100. 100.
    Jabes, D., Nachman, S., and Tomasz, A., Penicillin-binding protein families: Evidence for the clonal nature of penicillin resistance in clinical isolates of pneumococci, J. Infect. Dis. 159:16–25 (1989).PubMedCrossRefGoogle Scholar
  101. 101.
    Jarvis, W. R., White, J. W., Mann, P. W., Mosser, J. L., Emori, T. G., Culver, D. H., Thornsberry, C., and Hughes, J. M., Nosocomial infection surveillance, 1983, Morbid. Mortal. Weekly Rep. 33:9SS–21SS (1984).Google Scholar
  102. 102.
    Jensen, N. E., Epidemiological aspects of human/animal interrelationships in Gbs, Antibiot. Chemother. 35:40–48 (1985).PubMedGoogle Scholar
  103. 103.
    Johnson, D. R., and Kaplan, E., Microtechnique for serum opacity factor for characterization of group A streptococci adaptable to the use of human sera, J. Clin. Microbiol. 26:2025–2030 (1988).PubMedGoogle Scholar
  104. 104.
    Johnston, K. H., and Zabriskie, J. B., Purification and partial characterization of the nephritis strain-associated protein from Streptococcus pyogenes, group A, J. Exp. Med. 163:697–712 (1986).PubMedCrossRefGoogle Scholar
  105. 105.
    Jones Criteria (Revised) for Guidance in Diagnosis of Rheumatic Fever, Circulation 69:203A–208A (1984).CrossRefGoogle Scholar
  106. 106.
    Jurgens, D., Sterzik, B., and Fehrenbach, F. J., Unspecific binding of group B streptococcal cocytolysin (Camp factor) to immunoglobins and its possible role in pathogenicity, J. Exp. Med. 165:720–732 (1987).PubMedCrossRefGoogle Scholar
  107. 107.
    Kaplan, E. L., The group A streptococcal upper respiratory tract carrier state: An enigma, J. Pediatr. 97:337–345 (1980).PubMedCrossRefGoogle Scholar
  108. 108.
    Kaplan, E. L., The rapid identification of group A betahemolytic streptococci in the upper respiratory tract, Pediatr. Clin North Am. 35:535–543 (1988).PubMedGoogle Scholar
  109. 109.
    Kaplan, E. L., Johnson, D. R., and Cleary, P. P., Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-1980s, J. Infect. Dis. 159:101–103 (1989).PubMedCrossRefGoogle Scholar
  110. 110.
    Kass, E. H., and Seastone, C. V., The role of the mucoid polysaccharide (hyaluronic acid) in the virulence of group A streptococci, J. Exp. Med. 79:319–330 (1944).PubMedCrossRefGoogle Scholar
  111. 111.
    Katz, V., and Bowes, W. A., Perinatal group B streptococcal infections across intact amniotic membranes, J. Reprod. Med. 33:445–449 (1988).PubMedGoogle Scholar
  112. 112.
    Kefalides, N. A., Pegg, M. T., Ohno, N., Poon-King, T., Zabriskie, J., and Fillit, H., Antibodies to basement membrane collagen and to laminin are present in sera from patients with poststreptococcal glomerulonephritis, J. Exp. Med. 163:588–602 (1986).PubMedCrossRefGoogle Scholar
  113. 113.
    Kim, K. S., and Kaplan, E. L., Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis, J. Pediatr. 107:681–684 (1985).PubMedCrossRefGoogle Scholar
  114. 114.
    Klein, J. O., Feigin, R. D., and Mccracken, G. H., Jr., Report of the task force on diagnosis and management of meningitis, Pediatrics 78(Suppl.): 959–982 (1986).PubMedGoogle Scholar
  115. 115.
    Koskela, M., Leinonen, M., Haiva, V., and Makala, P. H., First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants, Pediatr. Infect. Dis. J. 5:45–50 (1986).CrossRefGoogle Scholar
  116. 116.
    Lancefield, R. C., and Hare, R., The serological differentiation of pathogenic and nonpathogenic strains of hemolytic streptococci from parturient women, J. Exp. Med. 61:335–349 (1935).PubMedCrossRefGoogle Scholar
  117. 117.
    Lancefield, R. C., Mccarty, M., and Everly, W. N., Multiple mouse-protective antibodies directed against group B streptococci, J. Exp. Med. 142:165–179 (1975).PubMedCrossRefGoogle Scholar
  118. 118.
    Leclercq, M. H., Barmes, D. E., and Sardo Infirri, J., Oral health: Global trends and projections, World Health Stat. Q. 40:116–128 (1987).PubMedGoogle Scholar
  119. 119.
    Ledger, W., Norman, M., Gee, C., and Lewis, W., Bacteremia on an obstetric-gynecologic service, Am. J. Obstet. Gynecol. 121:205–212 (1975).PubMedGoogle Scholar
  120. 120.
    Liang, S. T., Lau, S. P., Chan, S. H., Fok, T. F., Murai, T., and Kaneko, Y., Perinatal colonization of group B streptococcus-An epidemiological study in a Chinese population, Aust. N.Z. Obstet. Gynaecol. 26:138–141 (1986).CrossRefGoogle Scholar
  121. 121.
    Loda, F. A., Collier, A. M., Glezen, W. P., Strangert, K., Clyde, W. A., and Denny, F. W., Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children, J. Pediatr. 87:1087–1093 (1975).PubMedCrossRefGoogle Scholar
  122. 122.
    Loesche, W. J., Role of Streptococcus mutans in human dental decay, Microbiol. Rev. 50:353–380 (1986).PubMedGoogle Scholar
  123. 123.
    Lue, C., Tarkowski, A., and Mestecky, J., Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood leukocytes and increases of both serum and secretory antipneumococcal antibodies, J. Immunol. 140:3793–3800 (1988).PubMedGoogle Scholar
  124. 124.
    Luginbuhl, L. M., Rotbart, H. A., Facklam, R. R., Roe, M. H., and Elliot, J. A., Neonatal enterococcal sepsis: Case-control study and description of an outbreak, Pediatr. Infect. Dis. J. 6:1022–1026 (1987).PubMedGoogle Scholar
  125. 125.
    Macleod, C. M., Hodges, R. G., Heidelberger, M., and Bernhard, W. G., Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides, J. Exp. Med. 82:445–465 (1945).CrossRefGoogle Scholar
  126. 126.
    Maddox, J. S., Ware, J. C., and Dillon, H. C., Jr., The natural history of streptococcal skin infection: Prevention with topical antibiotics, Am. J. Acad. Dermatol. 13:207–212 (1985).CrossRefGoogle Scholar
  127. 127.
    Majeed, H. A., Khuffash, F. A., Sharda, D. C., Farwana, S. S., El-Sherbiny, A., and Gharour, S. Y., Children with acute rheumatic fever and acute poststreptococcal glomerulonephritis and their families in a subtropical zone: A three-zone prospective comparative epidemiological study, Int. J. Epidemiol. 16:561–586 (1987).PubMedCrossRefGoogle Scholar
  128. 128.
    Maki, D. G., and Agger, W. A., Enterococcal bacteremia: Clinical features, the risk of endocarditis, and management, Medicine 67:248–269 (1988).CrossRefGoogle Scholar
  129. 129.
    Manji, F., Fejerskov, O., and Baelum, V., Pattern of dental caries in an adult rural population, Caries Res. 23:55–62 (1989).PubMedCrossRefGoogle Scholar
  130. 130.
    Markowitz, M., and Gerber, M. D., Rheumatic fever: Recent outbreaks of an old disease, Conn. Med. 51:229–233 (1987).PubMedGoogle Scholar
  131. 131.
    Matter, L., Wilhelm, J. A., Angehrn, W., Skvaril, F., and Schopfer, K., Selective antibody deficiency and recurrent pneumococcal bacteremia in a patient with Sjogren’s syndrome, hyperimmunoglobulinemia G, and deficiencies of IgG2 and IgG4, N. Engl. J. Med. 312:1039–1042 (1985).PubMedCrossRefGoogle Scholar
  132. 132.
    Mayon-White, R. T., The incidence of Gbs disease in neonates in different countries, Antibiot. Chemother. 35:17–27 (1985).PubMedGoogle Scholar
  133. 133.
    Mcdaniel, L. S., Yother, J., Vijayakumar, M., Mcgarry, L., Guild, W. R., and Briles, D. E., Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA), J. Exp. Med. 165:381–394 (1987).PubMedCrossRefGoogle Scholar
  134. 134.
    Mcfall, T. L., Zimmerman, G. A., Augustine, N. H., and Hill, H. R., Effect of group B streptococcal type-specific antigen on polymorphonuclear leukocyte function and polymorphonuclear leukocyte-endothelial cell interaction, Pediatr. Res. 21:517–523 (1987).PubMedCrossRefGoogle Scholar
  135. 135.
    Michalek, S. M., and Childers, N. K., Development and outlook for a caries vaccine, Crit. Rev. Oral Biol. Med. 1:37–54 (1990).PubMedGoogle Scholar
  136. 136.
    Miller, L., Burdett, V., Poirier, T. P., Gray, L. D., Beachey, E. H., and Kehoe, M. A., Conservation of protective and nonprotective epitopes in M proteins of group A streptococci, Infect. Immun. 56:2198–2204 (1988).PubMedGoogle Scholar
  137. 137.
    Milligan, T. W., Baker, C. J., Straus, D. C., and Mattingly, S. J., Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci, Infect. Immun. 21:738–746 (1978).PubMedGoogle Scholar
  138. 138.
    Mufson, M. A., Oley, G., and Hughey, D., Pneumococcal disease in a medium-sized community in the United States, Am. Med. Assoc. 248:1486–1489 (1982).CrossRefGoogle Scholar
  139. 139.
    Musher, D. M., Chapman, A. J., Goree, A., Jonsson, S., Briles, D., and Baughn, R. E., Natural and vaccine-related immunity to Streptococcus pneumoniae, J. Infect. Dis. 154:245–256 (1986).CrossRefGoogle Scholar
  140. 140.
    Nelson, J. D., Dillon, H. C., Jr., and Howard, J. B., A prolonged nursery epidemic associated with a newly recognized type of group A streptococcus, J. Pediatr. 89:792–796 (1976).PubMedCrossRefGoogle Scholar
  141. 141.
    O’Connor, S. P., and Cleary, P. P., In vivo Streptococcus pyogenes C5a peptidase activity: Analysis using transposonand nitrosoguanidine-induced mutants, J. Infect. Dis. 156:495–504 (1987).PubMedCrossRefGoogle Scholar
  142. 142.
    Olson, T. A., Fischer, G. W., Hemming, V. G., O’Brian, W. F., Golden, S. M., and Maybee, D. A., A group B streptococcal extract reduces neutrophil counts and induces neutrophil aggregation, Pediatr. Res. 21:326–330 (1988).CrossRefGoogle Scholar
  143. 142.
    Olson, T. A., Fischer, G. W., Hemming, V. G., O’Brian, W. F., Golden, S. M., and Maybee, D. A., A group B streptococcal extract reduces neutrophil counts and induces neutrophil aggregation, Pediatr. Res. 21:326–330 (1988).CrossRefGoogle Scholar
  144. 144.
    Paradise, J. L., Bluestone, C. D., Bachman, R. Z., Colborn, D. K., Bernard, B. S., Taylor, F. H., Rogers, K. D., Schwarzbach, R. H., Stool, S. E., Friday, G. A., Smith, I. H., and Saez, C. A., Efficacy of tonsillectomy for recurrent throat infection in severely affected children, N. Engl. J. Med. 310:674–683 (1984).PubMedCrossRefGoogle Scholar
  145. 145.
    Parker, M. T., Streptococcus and lactobacillus, in: Topley and Wilson’s Principles of Bacteriology, Virology and Immunity, Volume 2 (M. T. Parker, ed.), pp. 173–217, Williams & Wilkins, Baltimore, 1983.Google Scholar
  146. 146.
    Pass, M. A., Khare, S., and Dillon, H. C., Jr., Twin pregnancies: Incidence of group B streptococcal colonization and disease, J. Pediatr. 94:635–637 (1980).Google Scholar
  147. 147.
    Payne, N. R., Kim, Y., and Ferrieri, P., Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of “c” proteinpositive and negative strains of type Ii group B streptococci, Infect. Immun. 55:1243–1251 (1987).PubMedGoogle Scholar
  148. 148.
    Payne, N. R., Burke, B. A., Day, D. L., Christenson, P. D., Thompson, T. R., and Ferrieri, P., Correlation of clinical and pathologic findings in early onset neonatal group B streptococcal infection with disease severity and prediction of outcome, Pediatr. Infect. Dis. J. 7:836–847 (1988).PubMedGoogle Scholar
  149. 149.
    Perry, W. D., Siegel, A. C., and Rammelkamp, C. J., Jr., Transmission of group A streptococci. Ii. The role of contaminated dust, Am. J. Hyg. 66:96–101 (1957).PubMedGoogle Scholar
  150. 150.
    Perry, W. D., Siegel, A. C., Rammelkamp, C. J., Jr., Wannamaker, L. W., and Marple, C. E., Transmission of group A streptococci. I. The role of contaminated bedding, Am. J. Hyg. 66:85–95 (1957).PubMedGoogle Scholar
  151. 151.
    Philips, J. B., III, Lyrene, R. K., Godoy, G., Graybar, G., Barefield, E., Sams, J. E. P., and Gray, B. M., Hemodynamic responses of chronically instrumented piglets to bolus injections of group B streptococci, Pediatr. Res. 23:81–85 (1988).PubMedGoogle Scholar
  152. 152.
    Pichichero, M. E., Disney, F. A., Talpey, W. B., Green, J. L., Francis, A. B., Roghmann, K., and Hoekelman, R. A., Adverse and beneficial effects of immediate treatment of group A beta-hemolytic streptococcal pharyngitis with penicillin, Pediatr. Infect. Dis. J. 6:635–643 (1987).PubMedCrossRefGoogle Scholar
  153. 153.
    Pichichero, M. E,. Disney, F. A., Talpey, W. B., Green, J. L., Francis, A. B., Roghmann, K., and Hoekelman, R. A., Delayed treatment for strep throat (reply), Pediatr. Infect. Dis. J. 6:1140 (1987).Google Scholar
  154. 154.
    Poirier, T. P., Kehoe, M. A., and Beachey, E. H., Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein, J. Exp. Med. 168:25–32 (1988).PubMedCrossRefGoogle Scholar
  155. 155.
    Poirier, T. P., Kehoe, M. A., Whitnack, E., Dokter, M. E., and Beachey, E. H., Fibrinogen binding and resistance to phagocytosis of Streptococcus sanguis expressing cloned M protein of Streptococcus pyogenes, Infect. Immun. 57:29–35 (1989).Google Scholar
  156. 156.
    Potter, E. V., Lipschultz, S. A., Abidh, S., Poon-King, T., and Earle, D. P., Twelve to seventeen-year follow-up of patients with poststreptococcal acute glomerulonephritis in Trinidad, N. Engl. J. Med. 307:725–729 (1982).PubMedCrossRefGoogle Scholar
  157. 157.
    Pritchard, D. G., Egan, M. E., Gray, B. M., and Dillon, H. C., Jr., Immunochemical characterization of the polysaccharide antigens of group B streptococci, Rev. Infect. Dis. 10(Suppl. 2):S367–S371 (1988).Google Scholar
  158. 158.
    Pyati, S. P., Pildes, R. S., Jacobs, N. M., Ramamurthy, R. S., Yeh, T. F., Raval, D. S., Lillien, L. D., Amma, P., and Metzger, W. I., Penicillin in infants weighing two kilograms or less with early-onset group B streptococcal disease, N. Engl. J. Med. 308:1383–1389 (1983).PubMedCrossRefGoogle Scholar
  159. 159.
    Quinn, R. W., Streptococcal infections, in: Bacterial Infections of Humans (A. S. Evans and H. A. Feldman, eds.), pp. 525–552, Plenum Medical, New York, 1982.CrossRefGoogle Scholar
  160. 160.
    Raff, H. V., Siscoe, P. J., Wolff, E. A., Maloney, G., and Shuford, W., Human monoclonal antibodies to group B streptococcus, J. Exp. Med. 168:905–917 (1988).PubMedCrossRefGoogle Scholar
  161. 161.
    Robbins, J. B., Austrian, R., Lee, C., Rastogi, S. C., Schiffman, G., Henrichsen, J., Makala, P. H., Broome, C. V., Facklam, R. R., Tiesjema, R. H., and Park, J. C., Jr., Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with Emphasis on the cross-reactive type within groups, J. Infect. Dis. 148:1136–1159 (1983).PubMedCrossRefGoogle Scholar
  162. 162.
    Schleifer, K. H., and Kilpper-Balz, R., Transfer of Streptococcus faecalis and Streptococcus faecium to the genus Enterococcus nom. rev. as Enterococcus faecalis comb. nov. and Enterococcus faecium comb. nov., Int. J. Syst. Bacteriol. 34:31–34 (1984).CrossRefGoogle Scholar
  163. 163.
    Shann, F., Etiology of severe pneumonia in children in developing countries, Pediatr. Infect. Dis. J. 5:247–252 (1986).CrossRefGoogle Scholar
  164. 164.
    Shapiro, E. D., and Clemens, J. D., A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk for serious pneumococcal infections, Ann. Intern. Med. 101:325–330 (1984).PubMedGoogle Scholar
  165. 165.
    Smith, T. D., Wilkinson, V., and Kaplan, E. L., Group A Streptococcus-associated upper respiratory tract infections in a day-care center, Pediatrics 83:380–384 (1989).PubMedGoogle Scholar
  166. 166.
    Spigelblatt, L., Saintonge, J., and Chicoine, R., Changing pattern of neonatal streptococcal septicemia, Pediatr. Infect. Dis. J. 4:56–58 (1985).CrossRefGoogle Scholar
  167. 167.
    Stein, D. S., and Nelson, K. E., Endocarditis due to nutritionally deficient streptococci, Rev. Infect. Dis. 9:908–916 (1987).PubMedCrossRefGoogle Scholar
  168. 168.
    Stollerman, G. H., Changing group A streptococci: The reappearance of streptococcal “toxic shock,” Arch. Intern. Med. 148:1268–1270 (1988).PubMedCrossRefGoogle Scholar
  169. 169.
    Stool, S. E., and Field, M. J., The impact of otitis media, Pediatr. Infect. Dis. J. 8(Suppl): S 11–514 (1989).CrossRefGoogle Scholar
  170. 170.
    Strobel, S., and Ferguson, A., Induction of oral tolerance, in mice, to gum arabic, Food Addit. Contam. 3:43–46 (1986).PubMedCrossRefGoogle Scholar
  171. 171.
    Thomas, R. J., Conwell, D. E., Morton, D. E., Brooks, T. J., Holmes, C. K., and Mahaffey, W. B., Penicillin prophylaxis for streptococcal infections in United States Navy and Marine Corps recruit camps, 1951–1985, Rev. Infect. Dis. 10:125–130 (1988).PubMedCrossRefGoogle Scholar
  172. 172.
    Tweten, R., Nucleotide sequence of the gene for perfingolysin O (theta-toxin) from Clostridium perfringens: Significant homology with genes for streptolysin O and pneumolysin, Infect. Immun. 56:3235–3240 (1988).PubMedGoogle Scholar
  173. 173.
    Van Der Rijn, I., and Kessler, R. E., Growth characteristics of group A streptococci in a new chemically defined medium, Infect. Immun. 27:444–448 (1980).PubMedGoogle Scholar
  174. 174.
    Veasy, L. G., Wiedmeier, S. E., Orsmond, G. S., Ruttenberg, H. D., Boucek, M. M., Roth, S. J., Tait, V. F., Thompson, J. A., Daly, J. A., Kaplan, E., and Hill, H. R., Resurgence of acute rheumatic fever in the intermountain area of the Untied States, N. Engl. J. Med. 316:421–427 (1987).PubMedCrossRefGoogle Scholar
  175. 175.
    Vogt, A., Batsford, S., Rodriguez-Iturbe, B., and Garcia, R., Cationic antigens in poststreptococcal glomerulonephritis, Clin. Nephrol. 20:271–279 (1983).PubMedGoogle Scholar
  176. 176.
    Wald, E. R., Bergman, I., Taylor, H. G., Chiponis, D., Porter, C., and Kubek, K., Long-term outcome of group B streptococcal meningitis, Pediatrics 77:217–221 (1986).PubMedGoogle Scholar
  177. 177.
    Wald, E. R., Dashefsky, B., Feidt, C., Chiponis, D., and Byers, C., Acute rheumatic fever in western Pennsylvania and the tristate area, Pediatrics 80:371–374 (1987).Google Scholar
  178. 178.
    Waltman, W. D., Gray, B., Mcdaniel, L. S., and Briles, D. E., Cross-reactive monoclonal antibodies for diagnosis of pneumococcal meningitis, J. Clin. Microbiol. 26:1635–1640 (1988).PubMedGoogle Scholar
  179. 179.
    Waltman, W. D. I., Mcdaniel, L. S., Andersson, B., Bland, L., Gray, B. M., Eden, C. S., and Briles, D. E., Protein serotyping of Streptococcus pneumoniae based on reactivity to six monoclonal antibodies, Microb. Pathogenesis 5:159–167 (1988).CrossRefGoogle Scholar
  180. 180.
    Wannamaker, L. W., Streptococcal toxins, Rev. Infect. Dis. 5(Suppl.): S723–S732 (1983).CrossRefGoogle Scholar
  181. 181.
    Weinstein, M. P., Reller, L., Murphy, J. R., and Lichtenstein, K. A., The clinical significance of positive blood cultures. A comprehensive analysis of 500 episodes of bacteremia and fungemia in adults-I. Laboratory and epidemiologic observations, Rev.. Infect. Dis. 5:35–53 (1983).PubMedCrossRefGoogle Scholar
  182. 182.
    Wessels, M. R., Pozsgay, V., Kasper, D. L., and Jennings, H. J., Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus, J. Biol. Chem. 262:8262–8267 (1987).Google Scholar
  183. 183.
    Who Study Group, Rheumatic fever and rheumatic heart disease, Who Tech. Rep. Ser. 764:1–58 (1988).Google Scholar
  184. 184.
    Willett, L. D., Dillon, H. C., Jr., and Gray, B. M., Penicillin-intermediate pneumococci in a children’s hospital, Am. J. Dis. Child. 139:1054–1057 (1985).PubMedGoogle Scholar
  185. 185.
    WooD, E. G., and Dillon, H. C., Jr., A prospective study of group B streptococcal bacteriuria in pregnancy, Am. J. Obstet. Gynecol. 140:515–520 (1981).PubMedGoogle Scholar
  186. 186.
    Yarnall, M., and Boyle, M. D. P., Isolation and characterization of type IIa and type IIb Fc receptors from group A streptococcus, Scand. J. Immunol. 24:549–557 (1986).PubMedCrossRefGoogle Scholar
  187. 187.
    Yeung, M. K., and Mattingly, S. J., Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci, Infect. Immun. 44:217–221 (1984).PubMedGoogle Scholar
  188. 188.
    Yoshimoto, M., Hosoi, S., Fujisawa, S., Sudo, M., and Okuda, R., High levels of antibodies to streptococcal cell membrane antigens specifically bound to monoclonal antibodies in acute poststreptococcal glomerulonephritis, J. Clin. Microbiol. 25:680–684 (1987).PubMedGoogle Scholar
  189. 189.
    Zawaneh, S. M., Ayoub, E. M., Baer, H., Cruz, A. C., and Spellacy, W. N., Factors influencing the adherence of group B streptococci to human vagina epithelial cells, Infect. Immun. 26:441–447 (1979).PubMedGoogle Scholar

12. Suggested Reading

  1. Christensen, K. K., Christensen, P., and Ferrieri, P. (eds.), Neonatal Group B Streptococcal Infections, Antibiot. Chemother. 35:1–347 (1985).Google Scholar
  2. Dunning, J. M., Principles of Dental Public Health, Harvard University Press, Cambridge, Mass., 1986.Google Scholar
  3. Heffron, R., Pneumonia with Special Reference to Pneumococcus Lobar Pneumonia, Commonwealth Fund, New York, 1939; reprinted by Harvard University Press, Cambridge, Mass., 1979.Google Scholar
  4. Kimura, Y., Kotami, S., and Shiokawa, Y. (eds.), Recent Advances in Streptococci and Streptococcal Diseases, Reedbooks, Brackness, Birkshire, U.K., 1985.Google Scholar
  5. Maki, D. G., and Agger, W. A., Enterococcal bacteremia: Clinical features, the risk of endocarditis, and management, Medicine 67:248–269 (1988).PubMedCrossRefGoogle Scholar
  6. Markowitz, M., and Gordis, L. Rheumatic Fever, 2nd ed., Saunders, Philadelphia, 1972.Google Scholar
  7. Third International Conference on Rheumatic Fever and Rheumatic Heart Disease, Rotorua 16–18 April 1987, N.Z. Med. J. 101:387–411 (1987).Google Scholar
  8. Wannamaker, L. W., and Matsen, J. M. (eds.), Streptococci and Streptococcal Diseases, Academic Press, New York, 1972.Google Scholar
  9. White, B. (with the collaboration of Robinson, E. S., and Barnes, L. A.), The Biology of the Pneumococcus: The Bacteriological, Biochemical and Immunological Characters and Activities of Diplococcus pneumoniae, Commonwealth Fund, New York, 1938; reprinted by Harvard University Press, Cambridge, Mass., 1979.Google Scholar
  10. Who Study Group, Rheumatic fever and rheumatic heart disease, Who Tech. Rep. Ser. 764:1–58 (1988).Google Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Barry M. Gray
    • 1
  1. 1.Department of PediatricsUniversity of Alabama School of MedicineBirminghamUSA

Personalised recommendations